Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y(12) Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study
CYP2C19基因型指导的P2Y(12)抑制剂治疗在慢性肾脏病患者经皮冠状动脉介入治疗后的安全性和有效性：TAILOR-PCI研究的事后分析
期刊:Cardiovascular Drugs and Therapy
影响因子:3.1
doi:10.1007/s10557-022-07392-2
Mathew, Roy O; Sidhu, Mandeep S; Rihal, Charanjit S; Lennon, Ryan; El-Hajjar, Mohammed; Yager, Neil; Lyubarova, Radmila; Abdul-Nour, Khaled; Weitz, Steven; O'Cochlain, D Fearghas; Murthy, Vishakantha; Levisay, Justin; Marzo, Kevin; Graham, John; Dzavik, Vlad; So, Derek; Goodman, Shaun; Rosenberg, Yves D; Pereira, Naveen; Farkouh, Michael E
